EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Heartbreakers and healers: RNA rebels in cardio-oncology

Celestina Agyemang-Dua, Charles S Chung, Cristina Espinosa-Diez

Seminars in Cancer Biology · 2026

DOI: 10.1016/j.semcancer.2025.12.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2026. Verfasst von Celestina Agyemang-Dua und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI 48202, USA. Hauptthemen laut MEDLINE: Neoplasms, Cardiotoxicity, RNA, Long Noncoding, Antineoplastic Agents. Die Arbeit nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer therapies save lives but often "break hearts" by damaging the cardiovascular system. As survival improves, therapy-induced cardiotoxicity has become a defining challenge of modern oncology. Recent discoveries reveal that long non-coding RNAs (lncRNAs), once dismissed as genomic noise, are the "RNA rebels" orchestrating cellular responses to cancer treatments. These molecules act as both heartbreakers and healers, amplifying or counteracting oxidative stress, mitochondrial dysfunction, apoptosis, and vascular injury. In anthracycline, radiation, and VEGF-targeted therapies, lncRNAs govern key processes that dictate whether cells succumb to damage or mount protective repair responses. Pro-injury lncRNAs exacerbate senescence and inflammation, while protective ones preserve mitochondrial homeostasis and limit cell death. Beyond mechanistic insight, these molecules hold clinical promise as biomarkers and therapeutic targets, guiding RNA-based strategies to predict, prevent, and treat cardiotoxicity. Understanding how they blur the line between protection and harm may redefine how we safeguard the heart in the era of precision cardio oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCardiotoxicityRNA, Long NoncodingAntineoplastic AgentsHumansAnimalsMedical OncologyCardio-Oncology

Stichwörter der Autor:innen

Cancer TherapyCardiotoxicityLncRNAs

Substanzen

RNA, Long NoncodingAntineoplastic Agents

Autor:innen und Institutionen

  • Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI 48202, USA.
  • Department of Physiology, Wayne State University, Detroit, MI 48202, USA.
  • Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI 48202, USA; Department of Physiology, Wayne State University, Detroit, MI 48202, USA. Electronic address: cristina.espinosa.diez@wayne.edu.

Förderung

  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute
  • National Institutes of Health
  • American Heart Association Inc

Zitieren

APA

Agyemang-Dua, C., Chung, C. S., & Espinosa-Diez, C. (2026). Heartbreakers and healers: RNA rebels in cardio-oncology. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2025.12.008

Vancouver

Agyemang-Dua C, Chung CS, Espinosa-Diez C. Heartbreakers and healers: RNA rebels in cardio-oncology. Seminars in Cancer Biology. 2026. doi:10.1016/j.semcancer.2025.12.008

BibTeX
@article{AgyemangDua2026,
  author = {Agyemang-Dua, Celestina and Chung, Charles S and Espinosa-Diez, Cristina},
  title = {Heartbreakers and healers: RNA rebels in cardio-oncology},
  journal = {Seminars in Cancer Biology},
  year = {2026},
  doi = {10.1016/j.semcancer.2025.12.008}
}
Kostenlos starten →